Things will be ok. All you need is the love of a good woman or the d of a bad man. 

---

> Members of Congress With the Best Performance in 2024 > Rep. David Rouzer (**R**-NC): 149.0% > Rep. Debbie Wasserman Schultz (D-FL): 142.3% > Sen. Ron Wyden (D-OR): 123.8% > Rep. Roger Williams (**R**-TX): 111.2% > Rep. Morgan McGarvey (D-KY): 105.8% > Rep. Larry Bucshon (**R**-IN): 98.6% > Rep. Pete Sessions (**R**-TX): 95.2% > Sen. Susan Collins (**R**-ME): 77.5% > Rep. David Kustoff (**R**-TN): 71.5% > *Rep. Nancy Pelosi (D-CA): 70.9%* Best grift the GOP did was somehow make everyone associate using political insider information to trade with the female Democratic speaker of the house.

---

Challenger Report: **US-based employers announced 153,074 job cuts in October 2025, the highest total for the month since 2003, compared with 54,064 in September.** Job cuts TRIPLED. **T R I P L E D.** And we are entering the holiday season. What is happening?

---

atleast qqq now hit a bottom, time to go back up, sadly no more money for calls :D

---

aaannnnd it’s GONE ;D

---

Why is D-wave reversing

---

Or that big D

---

$LENZ Q3 Highlights & Risks The Good: - 90% awareness of Eye Care Professionals - 5,000 scripts (most happened in final two weeks of Oct) by 2,500 ECPs 40% of which have done repeated scripts. - Sarah Jessica Parker direct to consumer campaign starts in Jan 2026. - Enough cash runway for 2-3 years of current operations. - Non-ECP Doctors want to be able to prescribe. - Side effects and concerns with prior failed drug company Vuity are not being experienced. The Bad: - Overcoming the negative stigma of Vuity(prior company first to market with drug that had terrible side effects). - 5,000 scripts is a good start but nowhere near enough. To reach 1 billion in revenue we need to trend towards 1 million scripts per year. If they double scripts each month and hats achieved in 10 months. - Increase in SG&A expenses - gotta spend money to make money. Q3 obviously had one off expenses so SG&A moving forward will be slightly lower and R&D will continue to tapper down. The Other: - I have been anecdotally polling individuals that have used the drops to understand side effects and if they are happy or not and will continue using. - 70-80% are happy with the experience. - 50% have explicitly stated they will continue to routinely use the drops. I remain optimistic and will continue to add to my position at these prices. Wish me luck regards. -SCO

---

How much more can D-wave dump today ? Have some out the money puts @29

---

D-wave only has 3.7m revenue? Lmfao how is this company even public

---